DGS Capital Management LLC cut its stake in shares of Relx Plc (NYSE:RELX – Free Report) by 6.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,233 shares of the technology company’s stock after selling 313 shares during the quarter. DGS Capital Management LLC’s holdings in Relx were worth $201,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of RELX. CWA Asset Management Group LLC acquired a new position in shares of Relx during the third quarter worth approximately $548,000. Choreo LLC acquired a new position in Relx during the second quarter worth $793,000. Creative Planning grew its holdings in shares of Relx by 16.4% during the second quarter. Creative Planning now owns 128,930 shares of the technology company’s stock valued at $5,915,000 after buying an additional 18,199 shares during the last quarter. International Assets Investment Management LLC bought a new stake in shares of Relx during the third quarter worth about $1,268,000. Finally, American Century Companies Inc. raised its holdings in shares of Relx by 6.8% in the 2nd quarter. American Century Companies Inc. now owns 362,511 shares of the technology company’s stock worth $16,632,000 after acquiring an additional 22,983 shares during the last quarter. 15.02% of the stock is owned by institutional investors.
Relx Trading Down 0.5 %
NYSE:RELX opened at $47.06 on Friday. Relx Plc has a 52 week low of $38.08 and a 52 week high of $48.91. The firm has a 50-day moving average price of $47.03 and a two-hundred day moving average price of $46.41.
Wall Street Analysts Forecast Growth
View Our Latest Report on Relx
About Relx
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.
Featured Stories
- Five stocks we like better than Relx
- Find and Profitably Trade Stocks at 52-Week Lows
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Market Cap Calculator: How to Calculate Market Cap
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.